Related Experiment Videos
[High-dose melphalan in patients with multiple myeloma]
P Moreau1, M Le Bonniec, J L Harousseau
1Service d'hématologie clinique, CHU Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes.
Bulletin Du Cancer
|April 22, 1999
Abstract:
Since 1983 an increasing number of clinical trials have used high-dose melphalan with or without autologous stem cell support in patients with multiple myeloma. It has been shown that high-dose therapy including high-dose melphalan may be considered as the treatment of choice in newly diagnosed patients. The purpose of this report is to review and summarize the clinical information on IV high-dose melphalan in patients with multiple myeloma and to examine potential areas of future investigation.